KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $120.9 million.

  • Idexx Laboratories' Capital Expenditures rose 10.77% to $31.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.5 million, marking a year-over-year increase of 0.22%. This contributed to the annual value of $120.9 million for FY2024, which is 9.51% down from last year.
  • As of FY2024, Idexx Laboratories' Capital Expenditures stood at $120.9 million, which was down 9.51% from $133.6 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Capital Expenditures peaked at $148.8 million during FY2022, and registered a low of $107.0 million during FY2020.
  • Its 3-year average for Capital Expenditures is $134.5 million, with a median of $133.6 million in 2023.
  • As far as peak fluctuations go, Idexx Laboratories' Capital Expenditures slumped by 30.98% in 2020, and later increased by 24.50% in 2022.
  • Idexx Laboratories' Capital Expenditures (Yearly) stood at $107.0 million in 2020, then increased by 11.77% to $119.5 million in 2021, then increased by 24.50% to $148.8 million in 2022, then dropped by 10.22% to $133.6 million in 2023, then fell by 9.51% to $120.9 million in 2024.